AmerisourceBergen elects Redonda Miller, M.D. to board, effective Jan 1, 2023

Cencora, Inc.

Dr. Miller is president of The Johns Hopkins Hospital; independent director under NYSE standards.
Annual cash retainer of $100,000 and equity award valued at $200,000 on grant date.
No related party transactions between Dr. Miller and the Company.
Previously served as non-executive director at Invivyd (formerly Adagio Therapeutics) until Oct 2022.
Also on boards of Gilchrist Hospice Care and Turnaround Tuesday.

item 5.02 item 7.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Redonda G. Miller, M.D.

Director

COR · Cencora, Inc.

Effective: 2023-01-01
Filed: November 16, 2022, 6:59 PM ET

On November 9, 2022, the Board of Directors (the “Board”) of AmerisourceBergen Corporation (the “Company”) elected Redonda G. Miller, M.D., 56, to serve on the Board, effective January 1, 2023.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Redonda G. Miller, M.D. was elected as Director at Cencora, Inc..

Action: elected
Role: Director

Exact text from the filing

On November 9, 2022, the Board of Directors (the “Board”) of AmerisourceBergen Corporation (the “Company”) elected Redonda G. Miller, M.D., 56, to serve on the Board, effective January 1, 2023.

View on SEC.gov

Cencora, Inc. filing history →

Source: SEC EDGAR

accession 0001140859-22-000095

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.